4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-019038
Director bought 2,500 shares at $3.98 ($9,950)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Richard John P Director | 2020-03-13 | Purchase | +2,500 | $3.98 | $9,950 | 3,716 | D: show line 1 in the form |
| Open-market purchases · 2,500 sh · avg $3.98 · $9,950 | |||||||
Loading xslF345X03/doc4.xml…